GMP-based management
GMP stands for Good Manufacturing Practice, which in Japanese is "a standard for manufacturing control and quality control of pharmaceuticals, quasi-drugs, etc."
As mentioned above, it is widely used not only in the pharmaceutical industry but also in the health food and supplement industries.
In Japan, management is primarily based on the Ministry of Health, Labour and Welfare's GMP Ministerial Ordinance (J-GMP).
Some organizations also operate the US FDA's cGMP and the European EU GMP together, depending on the company's backbone, export partner country, and trading area.
(These three major GMPs are called trilateral GMPs.)
Reference link: Ministry of Health, Labour and Welfare Ministerial Ordinance on Standards for Manufacturing Control and Quality Control of Pharmaceuticals and Quasi-drugs (GMP Ministerial Ordinance)
Since the establishment of the Trilateral GMP, it has been increasingly problematic that GMPs operated in different regions of each country have differences in management levels and auditing standards.
Therefore, in 2000, the PIC/S GMP, a unified international standard, was established by an organization called PIC/S, which is comprised of member auditing authorities from each country.
Currently, it is no exaggeration to say that adoption is an essential GMP management standard for pharmaceutical companies with a global presence.
In all GMP management regulations, product quality is not relied solely on final inspection, but rather on the acceptance of raw materials, manufacturing processes, equipment, work procedures, record keeping, etc The basic management mechanism is based on three principles: "minimizing human error," "preventing contamination and quality degradation," and "designing systems that guarantee high quality." The regulations stipulate that equipment used in manufacturing and testing must be objectively recorded 『that it is in a state of proper use for its intended use』, and one of these efforts is validation.